| We will study whether non-cardiac drugs increase ventricular tachycardia/fibrillation (VT/VF) risk in the general population and/or in subgroups, e.g., patients with congestive heart failure or cardiac ischemia. Second, we will study whether VT/VF risk is particularly increased in patients with sodium channel gene variants that result in reduced depolarizing current. |
